Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namisol for Behavioural Disturbances and Pain in Dementia
NCT01608217Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) and vascular dementia comparing Namisol Arm with Placebo Arm (2 arms). Primary endpoint: Neuropsychiatric Inventory at 3 weeks. Started Jun 2012; status: completed.
02
Drugs
dronabinol
03
Conditions
Alzheimer's disease (AD)vascular dementia
Beyond the preview
Go deeper on NCT01608217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01608217.